Numelvi has just arrived. It works remarkably well. But the full story deserves your attention.

If your dog scratches, licks, chews and rubs themselves raw you know the helplessness of watching that and not being able to fix it. The nights of interrupted sleep. The vet visits. The endless elimination diets. The creams that don't quite cut it.

So, when a new drug arrives promising to stop that itch within two to four hours, with over 80% of dogs showing meaningful improvement, it's completely understandable that pet parents and vets alike would get excited. And the excitement around Numelvi (atinvicitinib), FDA-approved in February 2026 and now making its way to New Zealand veterinary clinics, is real and largely warranted.

But as someone who works with animals every day and cares deeply about their long-term wellbeing, I want to give you the full picture because the clinical trial data tells a more complicated story than the headlines suggest. You deserve to make an informed choice, not just a hopeful one.

What Is Numelvi, and How Does It Work?

Numelvi is a once-daily tablet that targets a specific enzyme in your dog's body called JAK1 (Janus kinase 1). To understand what this drug does, you first need to understand what JAK1 normally does because this is where the story gets interesting.

Think of your dog's immune system as a vast internal communications network. When an allergen: pollen, dust mites, a certain food protein triggers a reaction, immune cells send out chemical messenger signals called cytokines. One of the most important itch-triggering cytokines is called IL-31. When IL-31 arrives at a cell and knocks on the door, JAK1 is the enzyme that opens it and sounds the alarm: itch, inflame, scratch.

Analogy Imagine JAK1 as the internal switchboard operator inside your dog's cells. When the "itch signal" phone rings from outside, JAK1 picks it up and routes the call through the building, setting off sirens everywhere. Numelvi essentially unplugs the switchboard - the phone still rings, but nobody answers, and the building stays quiet.

That sounds ideal. And for short-term relief, it genuinely can be. Numelvi is more selective than previous JAK inhibitors like Apoquel meaning it's more precisely targeted at JAK1 rather than clumsily blocking all JAK enzymes at once. In trials, over 81% of dogs experienced meaningful itch relief, and 87.5% of dogs with atopic dermatitis saw at least a 50% reduction in itching and skin lesions.

It works. That part is not in question. What is in question is what else gets switched off along with the itch.

The Problem: JAK1 Does a Lot More Than Trigger Itching

Here's what the product brochures won't lead with. JAK1 is not just an "itch enzyme." It is a foundational part of how your dog's body functions at a cellular level — every single day, quietly, behind the scenes.

Analogy Imagine you have a faulty alarm in one room of your house that keeps going off. That alarm is wired into the same electrical circuit as your smoke detectors, your security system, and your fridge. When you cut the power to silence the annoying alarm, you've also switched off everything else on that circuit. The house is quieter, but also less protected.

JAK1's normal, healthy roles in your dog's body include:

·     Antiviral Defence JAK1 is central to the body's interferon signalling system - the rapid-response team that detects and fights viruses. Suppressing it reduces your dog's front-line defence against viral infections.

·     Cancer Cell Surveillance One of the immune system's quiet, ongoing jobs is to identify and destroy abnormal (pre-cancerous) cells before they can multiply. JAK1 is part of this patrol system. When it's inhibited long-term, that patrol is weakened.

·     Blood Cell Formation JAK1 plays a critical role in how bone marrow produces healthy white blood cells  the very cells that fight infection and disease.

·     Brain Function Research shows the JAK-STAT pathway (of which JAK1 is part) is active in the cortex, hippocampus and cerebellum, and is linked to serotonin pathways affecting mood and stress responses. The implications for long-term use are not yet fully understood.

·     Life Itself When scientists breed mice with no JAK1 at all, those mice die at birth. This tells you, more powerfully than any drug company literature can, just how fundamental this enzyme is to being alive.

"We are not talking about switching off a minor background process. We are talking about partially dimming one of the body's most essential control systems, indefinitely."

The Clinical Trial: What the Data Actually Shows

The pivotal real-world efficacy trial for Numelvi involved 288 dogs across 26 veterinary clinics in the United States. The results were impressive. But here is a fact that should give every pet parent pause:

The Trial Lasted Just 28 Days

The main field study - the one used to support FDA approval - ran for only four weeks. That is the entire basis for our current knowledge of how this drug performs in real dogs living real lives.

Twenty-eight days cannot tell us anything meaningful about cancer risk, long-term immune suppression, organ effects, or what happens when a dog takes this tablet every single day for two, three, or five years.

The drug company's own label openly acknowledges this: "The effectiveness and safety of Numelvi have not been evaluated in a field study beyond 28 days." There were additional laboratory studies in Beagles lasting up to six months, but these were at controlled doses in laboratory settings, not real-world conditions.

The Cancer Question Is Unanswered

Numelvi's label includes a warning that "new neoplastic conditions (benign and malignant tumours) have been reported in dogs treated with other JAK inhibitors." This is a direct reference to Apoquel (oclacitinib), which has been associated with cancer in post-market surveillance — data that only emerged years after the drug was widely prescribed.

No cancers were reported in Numelvi's trial. But a 28-day trial in a few hundred dogs is not capable of detecting cancer risk. It simply is not long enough. The honest truth is: we do not yet know whether Numelvi carries the same cancer risk as Apoquel. We will not know for several more years of widespread use — by which point, many of today's dogs will have been on it for a long time.

Serious Findings in Overdose Studies

In the higher-dose laboratory studies, one dog developed a severe, progressive immune collapse — generalised demodicosis (a mange-like condition caused by immune failure), fever, swollen lymph nodes, and skin infections. The dog deteriorated and was euthanised on Day 175. This was at five times the recommended dose, but it illustrates in stark terms what happens when JAK1 suppression goes too far.

Male dogs in treatment groups also showed decreased testicular weight and microscopic changes to testicular tissue. The long-term reproductive and hormonal implications of this are not yet understood.

But What About the Itch? Isn't Stopping It Worth It?

This is the most human question, and the most understandable one. Watching your dog suffer is genuinely distressing. Itching, scratching, and skin inflammation cause real pain, real sleeplessness, and real damage to your dog's quality of life. That is not trivial.

But here's the thing: itching is a symptom, not a disease. It is your dog's body sending up a flare - a signal that something, somewhere, is out of balance. Numelvi, like Apoquel and Cytopoint before it, silences that flare. It does not put out the fire that lit it.

Analogy: Imagine your car's check engine light comes on. You could disconnect the warning light so it stops annoying you and the drive would be more comfortable. But the engine problem that triggered the light is still there, quietly progressing. Numelvi is, in a very real sense, a sophisticated way of disconnecting the warning light.

What actually causes allergic dermatitis in dogs? The triggers are many and varied: environmental allergens, food sensitivities, gut dysbiosis, toxic load, parasites, and underlying immune dysregulation. These rarely exist in isolation. For many dogs, the itch has a root cause that can be identified and addressed, rather than chemically suppressed, indefinitely, at the cost of immune function.

What If You Could Find the Real Reason Your Dog Is Itching?

At our clinic, we take a fundamentally different approach to the itchy dog. Rather than suppressing the immune system's response, we use bio-energetic resonance technology to investigate why the body is reacting in the first place.

Bio-energetic testing works on the principle that every cell, organ, and system in the body operates at specific frequencies and that imbalances, sensitivities, and stressors create measurable disturbances in those frequencies. Our devices scan your dog's energetic field to identify the underlying triggers: whether that's a particular food protein, an environmental toxin, a gut imbalance, an emotional stressor, or something else entirely.

Analogy: Think of your dog's body as an orchestra. When every instrument is in tune and playing together, the result is health and harmony. When something is off: a string out of tune, a musician playing the wrong notes  the result is discord: symptoms like chronic itching. Bio-energetic testing is like having a conductor with perfect pitch walk through the orchestra and identify precisely which instrument is causing the problem. Metatherapy (frequency medicine) then delivers the corrective notes back to the body, helping it come back into harmony.

Once we've identified the root imbalances, we use metatherapy (frequency medicine) to support the body's own healing processes, working with the body's intelligence rather than overriding it. This is not about suppressing a symptom. It's about restoring balance, so the symptom no longer needs to exist.

This approach doesn't replace all conventional care.  There are situations where short-term medical management is genuinely necessary. But for the many dogs with chronic itching who are being offered a lifetime of immune-suppressing medication, it is worth asking: have we actually looked for the cause?

So Should You Use Numelvi?

That is ultimately a decision for you and your vet, made together with full knowledge of the risks and benefits. Here is an honest summary to help guide that conversation:

·     Numelvi works, and works quickly.  For dogs with severe allergic skin disease, the relief it provides is real and meaningful. It is more targeted than Apoquel and may have a better safety profile, although we cannot yet know this for certain.

·     Long-term safety data does not exist yet.  The 28-day trial window means you and your dog are, in effect, part of the long-term safety study. That is not a scare tactic, it is simply the honest reality of how early-stage drug approval works.

·     The cancer question remains open.  Given what we know from Apoquel, the class-level risk of neoplasia with long-term JAK inhibition is real. It may be lower with Numelvi - or similar. We will not know for years.

·     The cause of your dog's itch deserves investigation.  Before committing to daily immune suppression for the rest of your dog's life, it is worth genuinely exploring what is driving the itch in the first place. You may be surprised by what can be found - and addressed.

Find Out What's Really Behind Your Dog's Itch

If your dog is struggling with chronic itching, skin problems, or allergic symptoms, we'd love to help you get to the bottom of it - naturally, and without guesswork.

Our bio-energetic resonance assessments through our wellness clinic Pure Harmonics, are non-invasive, stress-free for your animal, and often reveal sensitivities and imbalances that conventional testing misses entirely. We then work with our metatherapy frequency devices to support your dog's body in rebalancing - addressing the root cause, not just the symptom.

Because your dog deserves more than a lifetime of managing symptoms. They deserve answers.

Pure Harmonics www.pureharmonics.co.nz

Maria Brown, Naturopathic Nutritionist and Petscan Therapist

This article is written for informational purposes and to support informed conversations between pet owners and their veterinarians. It does not constitute veterinary medical advice. Always consult a qualified veterinarian before starting, stopping, or changing any treatment for your pet.

© 2026 · Written with care for New Zealand pet families